Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Oct 4, 2022
Distillery Therapeutics
Inhibiting homotrimeric COL1 for pancreatic cancer
Read More
BioCentury
|
Feb 26, 2021
Distillery Therapeutics
Blocking COL1 for multiple sclerosis
DISEASE CATEGORY: Autoimmune disease
INDICATION: Multiple sclerosis (MS) Inhibiting fibrosis marker
COL1
could treat MS. In an experimental autoimmune encephalomyelitis (EAE) mouse model of MS,
Read More
BioCentury
|
Sep 12, 2019
Distillery Therapeutics
Tumor-targeted serum albumin-chemotherapy conjugates for improved delivery to breast and colorectal cancers
Read More
BioCentury
|
Apr 30, 2019
Distillery Therapeutics
BMP2/BMP6/activin A-based chimera for bone repair
Read More
BioCentury
|
Oct 25, 2018
Distillery Therapeutics
Pulmonary
Read More
BioCentury
|
Jan 12, 2018
Clinical News
IDMC recommends discontinuing Phase III of Axsome's AXS-02 for complex regional pain syndrome
Read More
BioCentury
|
Jun 14, 2017
Distillery Techniques
Imaging
Read More
BioCentury
|
Mar 24, 2017
Clinical News
HT-100 regulatory update
Read More
BioCentury
|
Mar 22, 2017
Clinical News
Akashi restarting development of DMD candidate
Read More
BioCentury
|
Oct 13, 2016
Product R&D
Elastic bones
A 3-D printable scaffold for bone repair
Read More
Items per page:
10
1 - 10 of 31